151 related articles for article (PubMed ID: 37523153)
1. Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study.
Franz A; Reuken PA; Guliyeva S; Rose M; Boden K; Stallmach A; Bruns T
J Int Med Res; 2023 Jul; 51(7):3000605231187941. PubMed ID: 37523153
[TBL] [Abstract][Full Text] [Related]
2. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
[TBL] [Abstract][Full Text] [Related]
3. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation.
Affeldt P; Di Cristanziano V; Grundmann F; Wirtz M; Kaiser R; Benzing T; Stippel D; Kann M; Kurschat C
Immun Inflamm Dis; 2021 Jun; 9(2):513-520. PubMed ID: 33559399
[TBL] [Abstract][Full Text] [Related]
5. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.
Kamar N; Abravanel F; Behrendt P; Hofmann J; Pageaux GP; Barbet C; Moal V; Couzi L; Horvatits T; De Man RA; Cassuto E; Elsharkawy AM; Riezebos-Brilman A; Scemla A; Hillaire S; Donnelly MC; Radenne S; Sayegh J; Garrouste C; Dumortier J; Glowaki F; Matignon M; Coilly A; Figueres L; Mousson C; Minello A; Dharancy S; Rerolle JP; Lebray P; Etienne I; Perrin P; Choi M; Marion O; Izopet J;
Clin Infect Dis; 2020 Aug; 71(5):1204-1211. PubMed ID: 31793638
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity.
Nijskens CM; Pas SD; Cornelissen J; Caliskan K; Hoek RA; Hesselink DA; van der Eijk AA; de Man RA
J Clin Virol; 2016 Jan; 74():82-7. PubMed ID: 26687439
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis E Virus Infection in Cancer Patients.
Chiu CY; Zhang HC; Westin J; Hosing C; Torres HA
Transplant Cell Ther; 2022 Nov; 28(11):788.e1-788.e5. PubMed ID: 36031077
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study.
Xhaard A; Roque-Afonso AM; Mallet V; Ribaud P; Nguyen-Quoc S; Rohrlich PS; Tabrizi R; Konopacki J; Lissandre S; Abravanel F; Latour RP; Huynh A
Viruses; 2019 Jul; 11(7):. PubMed ID: 31284515
[TBL] [Abstract][Full Text] [Related]
11. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience.
Carter M; Solsrud K; Yeddula S; Fitzmaurice MG; Singh A; Nagai S; Jafri SM
Transplant Proc; 2022 Sep; 54(7):1737-1741. PubMed ID: 35907694
[TBL] [Abstract][Full Text] [Related]
13. HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party.
Mikulska M; Penack O; Wendel L; Knelange N; Cornelissen JJ; Blijlevens N; Passweg J; Kroger N; Bruns A; Koenecke C; Bierings M; Piñana JL; Labussiere-Wallet H; Ghesquieres H; Diaz MA; Sampol A; Averbuch D; de la Camara R; Styczynski J
Bone Marrow Transplant; 2022 Feb; 57(2):167-175. PubMed ID: 34689177
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
[TBL] [Abstract][Full Text] [Related]
15. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
[TBL] [Abstract][Full Text] [Related]
16. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience.
Pischke S; Hardtke S; Bode U; Birkner S; Chatzikyrkou C; Kauffmann W; Bara CL; Gottlieb J; Wenzel J; Manns MP; Wedemeyer H
Liver Int; 2013 May; 33(5):722-6. PubMed ID: 23489973
[TBL] [Abstract][Full Text] [Related]
17. Ritonavir Blocks Hepatitis E Virus Internalization and Clears Hepatitis E Virus In Vitro with Ribavirin.
Primadharsini PP; Nagashima S; Takahashi M; Murata K; Okamoto H
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366538
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection.
Low EXS; Tripon E; Lim K; Tan PS; Low HC; Dan YY; Lee YM; Muthiah M; Loo WM; Koh CJ; Phyo WW; Pang J; Lim SG; Lee GH
World J Hepatol; 2019 Jun; 11(6):553-561. PubMed ID: 31293723
[TBL] [Abstract][Full Text] [Related]
19. Dosing ribavirin in hepatitis E-infected solid organ transplant recipients.
De Winter BCM; Hesselink DA; Kamar N
Pharmacol Res; 2018 Apr; 130():308-315. PubMed ID: 29499270
[TBL] [Abstract][Full Text] [Related]
20. An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients.
Kamar N; Lhomme S; Abravanel F; Cointault O; Esposito L; Cardeau-Desangles I; Del Bello A; Dörr G; Lavayssière L; Nogier MB; Guitard J; Ribes D; Goin AL; Broué P; Metsu D; Sauné K; Rostaing L; Izopet J
Transplantation; 2015 Oct; 99(10):2124-31. PubMed ID: 26214817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
